| Subject: | FDA Approves New Drugs for HIV-1 Treatment |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 8 Sep 2004 - 10:00 am |
| The FDA has approved two new drugs for the treatment of HIV-1 infection. HIV-2 infection differs from HIV-1 with HIV-2 developing more slowly and appears to be milder. HIV-2 infections are found predominantly in Africa. Patients infected with HIV-2 are less infectious early in the course of infection, however as the disease advances, HIV-2 infectiousness seems to increase - with the duration of this increased infectiousness shorter in the HIV-2 patient. Both HIV-1 and HIV-2 have the same modes... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
Related MCN Products:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
